Intensive insulin therapy and pentastarch resuscitation in severe sepsis
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationalBlood glucose control in patients with severe sepsis and septic shockImmunomodulation in sepsis: state of the art and future perspectiveSystemic Steroids in Severe Sepsis and Septic ShockHydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysisColloids versus crystalloids for fluid resuscitation in critically ill patientsInsulin for glycaemic control in acute ischaemic strokeHydroxyethyl starch (HES) versus other fluid therapies: effects on kidney functionColloids versus crystalloids for fluid resuscitation in critically ill patientsInsulin for glycaemic control in acute ischaemic strokeColloids versus crystalloids for fluid resuscitation in critically ill patientsPeri-operative glycaemic control regimens for preventing surgical site infections in adultsHydroxyethyl starch (HES) versus other fluid therapies: effects on kidney functionColloids versus crystalloids for fluid resuscitation in critically ill patientsInsulin for glycaemic control in acute ischaemic strokeChallenging orthodoxy in critical care trial design: physiological responsivenessStandards of medical care in diabetes--2012Pro/con debate: should synthetic colloids be used in patients with septic shock?Sickness-Associated Anorexia: Mother Nature's Idea of Immunonutrition?Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)The Use of Fluids in SepsisSources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regressionFluid therapy for septic shock resuscitation: which fluid should be used?Postoperative fluid managementGlycemic variability and glycemic control in the acutely ill cardiac patientAssessment and treatment of hyperglycemia in critically ill patientsVascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic VariabilityOptimal glycemic control in neurocritical care patients: a systematic review and meta-analysisShould hydroxyethyl starch solutions be totally banned?The future is now: software-guided intensive insulin therapy in the critically illSafety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trialsManagement of diabetes mellitus type-2 in the geriatric population: Current perspectivesFluid therapy in critical illnessProtocols in the management of critical illnessStress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!Ventilatory strategies and supportive care in acute respiratory distress syndromeNephroprotective Potential of Human Albumin Infusion: A Narrative ReviewClinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adultsAKI associated with cardiac surgery.
P2860
Q21092902-9116DA26-63B0-4F45-A4B5-2D5B86023B7CQ21203739-19639450-9E3F-4CD0-AF9F-4DDD70B1C128Q22305498-675E65B3-048A-4E12-965A-1F132DA4EBCFQ22305766-A7EF5BFB-9F8A-4346-849C-B1462312BEF3Q22306309-C7955AF3-E06E-46E8-A231-E87EE444AC48Q22306541-45C4C7D0-14A9-44A7-B796-2777072533FEQ24200866-215384FC-E5E2-41A3-A1D5-1E6CB653D156Q24201046-E1480DA2-06DA-44B7-94A4-FE195ADDE335Q24201083-6CA1E4CF-88DC-416F-A31A-E21FB309F7A4Q24202823-075DB343-0F9F-4BF9-A682-4654BCBA392EQ24234214-269A779C-C9CB-45BB-BD2E-DCEBC4C2119CQ24235605-5B7B66EE-FEDB-455B-A2F8-C0F920ADC7D1Q24240025-7713A71D-50BD-4E39-8789-3CCE028E1B49Q24240767-FEFD5579-4843-4161-8AC7-12A0951FFECAQ24243170-E6912B23-2F41-4B44-93F0-2780CFE107EAQ24243588-87678C8B-7D0C-4C98-A1B7-548DFF39D00BQ24282584-E8CAA82C-5C9F-4404-AF0B-CAE856D14EDAQ24632533-7F385B89-F141-4855-AC25-D72B4F16E304Q24654055-937A02B1-C6C0-42F9-801B-5137765357B7Q26738529-A1B49565-DDEF-418C-9781-5375AA04152DQ26745670-7E787DE4-8290-46D7-9E87-581C5AA1E685Q26747728-78227377-7A6B-4BB3-84E9-E9A58A8AD34EQ26796519-EE32E7ED-231B-4096-A87F-1DDA3A6401A9Q26796564-8914E79F-3E27-4343-9C99-25C84C4AC9CBQ26799400-4A4B4935-09C9-4686-92B0-48F800943E0CQ26821994-2C16FB12-EA16-4321-ADB2-A8A30273BF5EQ26852018-CA6374A4-E41C-4958-B7DC-74863731E767Q26852360-F0B78999-BB87-4108-82EE-750999B4013BQ26858961-4F4AE773-A994-4827-BEF8-FB3582A86B05Q26859356-8403263A-2D6E-40D4-915B-43E555B19D32Q26864579-5C1DE8C2-86B0-43B2-A428-F7C1C2CE5455Q26991990-1D408D25-2409-4921-B8B8-70A81F45404BQ26999670-9EB99F58-AFBF-47CE-8584-D143CA144B87Q27000211-012D3779-738A-42A2-9EA6-6F4950118FB3Q27002502-7C00AF18-77DF-4A03-97B2-494C54E15BECQ27003097-F44371A3-6194-4D4B-825C-93024565D6FAQ27013107-F179672E-4535-41A4-B8AA-1D406B4C0639Q27015842-34B4CD0D-AC94-4F66-9EE5-B41C674B789EQ27021638-3C466186-1FB7-40E0-BEBC-6EB7FA33555CQ27023234-D156CA97-8DFE-466F-9D0F-B79904F5E3E2
P2860
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@ast
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@en
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@nl
type
label
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@ast
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@en
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@nl
prefLabel
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@ast
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@en
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@nl
P2093
P50
P921
P3181
P356
P1476
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
@en
P2093
Andreas Meier-Hellmann
Charles Natanson
Christiane Hartog
Derk Olthoff
Evelyn Kuhnt
Frank Bloos
Frank M Brunkhorst
Konrad Reinhart
Markus Loeffler
Martin Schaefer
P304
P3181
P356
10.1056/NEJMOA070716
P407
P577
2008-01-10T00:00:00Z